+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • March 2026
  • 183 Pages
  • Global
From
US Urinary Tract Infection Therapeutics outlook to 2028 - Product Thumbnail Image

US Urinary Tract Infection Therapeutics outlook to 2028

  • Report
  • August 2023
  • 85 Pages
  • United States
From
Global Markets for Infectious Disease Treatments - Product Thumbnail Image

Global Markets for Infectious Disease Treatments

  • Report
  • July 2025
  • 186 Pages
  • Global
From
From
From
Opioid Induced Constipation Market - Global Forecast 2026-2032 - Product Thumbnail Image

Opioid Induced Constipation Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
From
From
From
Cancer Biologics Market Report 2023-2033 - Product Thumbnail Image

Cancer Biologics Market Report 2023-2033

  • Report
  • June 2023
  • 308 Pages
  • Global
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • March 2026
  • 293 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 192 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 196 Pages
  • Global
From
Loading Indicator